Skip to main content
OpenTrials

Clinical trial condition

Hyperoxaluria

Explore clinical trials studying Hyperoxaluria. Study availability and eligibility vary by location and protocol.

36 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Hyperoxaluria trial results

Completed

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

NCT03905694

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations
  • Clinical Trial Site Rochester, Minnesota, United States
  • Clinical Trial Site Houston, Texas, United States
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
View Trial Details
Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

NCT03350451

Conditions
AGT, Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • Clinical Trial Site Bordeaux, France
  • Clinical Trial Site Lyon, France
  • Clinical Trial Site Paris, France
  • Clinical Trial Site Bonn, Germany
View Trial Details
Completed

A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria

NCT03095885

Conditions
Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
  • Applied Research Center of Arkansas, Inc. Little Rock, Arkansas, United States
  • Regional Urology, LLC Shreveport, Louisiana, United States
  • Omega Medical Research Warwick, Rhode Island, United States
View Trial Details
Completed

Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria

NCT03456830

Conditions
Calculi, Enteric Hyperoxaluria, Female Urogenital Diseases, +12 more
Locations
  • Urology Centers of Alabama Birmingham, Alabama, United States
  • University of Alabama, Department of Urology Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Urological Associates of Southern Arizona Tucson, Arizona, United States
View all 63 locations
View Trial Details

Related conditions